Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Subcommittee of the American Academy of Neurology Evidence-based Review): Report of the Therapeutics and Technology Assessment Assessment: Botulinum Neurotoxin for the Treatment of Movement Disorders (an Assessment: Botulinum Neurotoxin for the Treatment of Movement Disorders (an Evidence-based Review)

2008;70;1699-1706 Neurology Jankovic, B. Karp, C. L. Ludlow, J. M. Miyasaki, M. Naumann and Y. So D. M. Simpson, A. Blitzer, A. Brashear, C. Comella, R. Dubinsky, M. Hallett, J. Subcommittee of the American Academy of Neurology evidence-based review): Report of the Therapeutics and Technology Assessment Assessment: Botulinum neurotoxin for the treatment of movement disorders (an This informatio...

Assessment: prevention of post-lumbar puncture headaches: report of the therapeutics and technology assessment subcommittee of the american academy of neurology.

Review of the literature on prevention of post-lumbar puncture headaches (PLPHAs) since the publication of the original assessment in 2000 yielded one study comparing use of cutting to atraumatic needles in diagnostic lumbar punctures, providing Class I evidence in favor of the atraumatic needle. Taken in conjunction with data from most studies in the anesthesiology literature, the Therapeutics...

Technology Assessment Subcommittee of the American Academy (an Evidence-based Review) : Report of the Therapeutics and Assessment: Botulinum Neurotoxin for the Treatment of Spasticity Assessment: Botulinum Neurotoxin for the Treatment of Spasticity (an Evidence-based Review)

2008;70;1691 Neurology D. M. Simpson, J-M Gracies, H. K. Graham, et al. of Neurology Technology Assessment Subcommittee of the American Academy (an evidence-based review) : Report of the Therapeutics and Assessment: Botulinum neurotoxin for the treatment of spasticity March 31, 2011 This information is current as of http://www.neurology.org/content/70/19/1691.full.html located on the World Wide...

Neuropsychological testing of adults: further considerations for neurologists.

The recent report on neuropsychological testing of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (AAN) has implications for neuropsychologists as well as neurologists. The subcommittee's report omits mention of standardized neuropsychological test batteries used by a majority of practicing neuropsychologists, and of the demonstrated validity of suc...

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines.